Aptinyx Profit Margin 2017-2021 | APTX
Current and historical gross margin, operating margin and net profit margin for Aptinyx (APTX) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Aptinyx net profit margin as of September 30, 2021 is 0%.
|Aptinyx Annual Profit Margins
|Aptinyx Quarterly Profit Margins
||Medical - Biomedical and Genetics
Aptinyx Inc. is a bio-pharmaceutical company. It focuses on discovery, development, and commercialization of novel, proprietary and synthetic small molecules for the treatment of brain and nervous system disorders. The company's product pipeline consists of NYX-2925, NYX-783 and NYX-458 which are in clinical stage. Aptinyx Inc. is based in IL, United States.